Reuters: Merck, Schering delay earnings for Vytorin update

[chris]

Merck, Schering delay earnings for Vytorin update
      

NEW YORK (Reuters) - Merck & Co  and Schering-Plough  said they would delay release of company earnings until after the stock market closes on Monday, in order to update investors on a new important study of their shared Vytorin cholesterol fighter.
<p>You are not allowed to view links. Register or Login</p><div class="feedflare">
You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login
</div><img src="You are not allowed to view links. Register or Login" height="1" width="1"/>
      

You are not allowed to view links. Register or Login